4//SEC Filing
McCall Patrick 4
Accession 0001415889-25-012288
CIK 0001740279other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:45 PM ET
Size
17.0 KB
Accession
0001415889-25-012288
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
McCall Patrick
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Series A Warrants (right to buy)
2025-04-30−15,000→ 0 totalExercise: $0.18Exp: 2025-05-02→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2025-04-30$0.18/sh+15,000$2,766→ 67,071 total - Disposition to Issuer
Series A Warrants (right to buy)
2025-04-27−15,000→ 5,492 totalExercise: $0.45Exp: 2025-10-04→ Common Stock (15,000 underlying) - Disposition to Issuer
Series B Warrants (right to buy)
2025-04-27−20,492→ 0 totalExercise: $1.50Exp: 2028-12-13→ Common Stock (20,492 underlying) - Award
Series A Warrants (right to buy)
2025-04-27+15,000→ 15,000 totalExercise: $0.18Exp: 2025-05-02→ Common Stock (15,000 underlying) - Award
Series B Warrants (right to buy)
2025-04-27+20,492→ 20,492 totalExercise: $0.45Exp: 2028-12-13→ Common Stock (20,492 underlying)
Footnotes (4)
- [F1]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025 in regards to 15,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. The remaining 5,492 warrant shares are unchanged.
- [F2]Fully vested and exercisable.
- [F3]The reported securities are included within 20,492 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.
- [F4]The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.
Documents
Issuer
IN8BIO, INC.
CIK 0001740279
Entity typeother
Related Parties
1- filerCIK 0001874384
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:45 PM ET
- Size
- 17.0 KB